One single signaling pathway for so many different biological functions: Lessons from the cyclic adenosine monophosphate/protein kinase A pathway-related diseases

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4355-4357

  Assié, Guillaume ^a,b  

^a INSERM   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; G PROTEIN COUPLED RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE; GONADORELIN; GONADOTROPIN; GROWTH HORMONE RELEASING FACTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHODIESTERASE IV; SEROTONIN; THYROTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN;

ACRODYSOSTOSIS; ALBRIGHT SYNDROME; BLOMSTRAND SYNDROME; BONE DISEASE; DYSOSTOSIS; EDITORIAL; ENDOCRINE FUNCTION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME INACTIVATION; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GNAS GENE; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PRKAR1A GENE; PSEUDOHYPOPARATHYROIDISM; PTHR1 GENE; SIGNAL TRANSDUCTION;

CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; DRUG RESISTANCE; DYSOSTOSES; FEMALE; HORMONES; HUMANS; INTELLECTUAL DISABILITY; MALE; OSTEOCHONDRODYSPLASIAS;

EID: 84870758157     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3659     Document Type: Editorial

References (18)

1. Beavo JA, Brunton LL 2002 Cyclic nucleotide research - still expanding after half a century. Nat Rev Mol Cell Biol 3:710-718 (Pubitemid 34987792)
2. Vassart G, Costagliola S 2011 G Protein-coupled receptors: mutations and endocrine diseases. Nat Rev Endocrinol 7:362-372
3. Lania A, Mantovani G, Spada A 2001 G Protein mutations in endocrine diseases. Eur J Endocrinol 145:543-559 (Pubitemid 33061899)
4. Levy I, Horvath A, Azevedo M, de Alexandre RB, Stratakis CA 2011 Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment. Curr Opin Pharmacol 11:689-697
5. Mason JS, Bortolato A, Congreve M, Marshall FH 2012 New insights from structural biology into the druggability of G proteincoupled receptors. Trends Pharmacol Sci 33:249-260
6. Stratakis CA 2012 Cyclic AMP, protein kinase A, and phosphodiesterases: proceedings of an international workshop. Horm Metab Res 44:713-715
7. Mantovani G 2011 Clinical review: Pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab 96:3020-3030
8. Linglart A, Menguy C, Couvineau A, Auzan C, Gunes Y, Cancel M, Motte E, Pinto G, Chanson P, Bougnères P, Clauser E, Silve C 2011 Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N Engl J Med 364:2218-2226
9. Nagasaki K, Iida T, Sato H, Ogawa Y, Kikuchi T, Saitoh A, Ogata T, Fukami M 2012 PRKAR1A mutation affecting cAMP-mediated G protein-coupled receptor signaling in a patient with acrodysostosis and hormone resistance. J Clin Endocrinol Metab 97:E1808-E1813
10. Silve C, Clauser E, Linglart A 2012 Acrodysostosis. Horm Metab Res 44:749-758
11. Lee H, Graham Jr JM, Rimoin DL, Lachman RS, Krejci P, Tompson SW, Nelson SF, Krakow D, Cohn DH 2012 Exome sequencing identifies PDE4D mutations in acrodysostosis. Am J Hum Genet 90:746-751
12. Michot C, Le Goff C, Goldenberg A, Abhyankar A, Klein C, Kinning E, Guerrot AM, Flahaut P, Duncombe A, Baujat G, Lyonnet S, Thalassinos C, Nitschke P, Casanova JL, Le Merrer M, Munnich A, Cormier-Daire V 2012 Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis. Am J Hum Genet 90:740-745
13. Jin SL, Richard FJ, Kuo WP, D'Ercole AJ, Conti M 1999 Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. Proc Natl Acad Sci USA 96:11998-12003 (Pubitemid 29502847)
14. Jobert AS, Zhang P, Couvineau A, Bonaventure J, Roume J, Le Merrer M, Silve C 1998 Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 102:34-40 (Pubitemid 28323827)
15. Linglart A, Fryssira H, Hiort O, Holterhus PM, Perez de Nanclares G, Argente J, Heinrichs C, Kuechler A, Mantovani G, Leheup B, Wicart P, Chassot V, Schmidt D, Rubio-Cabezas O, Richter-Unruh A, Berrade S, Pereda A, Boros E, Munoz-Calvo MT, Castori M, Gunes Y, Bertrand G, Bougneres P, Clauser E, Silve C 2012 PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance. J Clin Endocrinol Metab 97:E2328-E2338
16. Vezzosi D, Bertherat J 2011 Phosphodiesterases in endocrine physiology and disease. Eur J Endocrinol 165:177-188
17. Horvath A, Bertherat J, Groussin L, Guillaud-Bataille M, Tsang K, Cazabat L, Libé R, Remmers E, René-Corail F, Faucz FR, Clauser E, Calender A, Bertagna X, Carney JA, Stratakis CA 2010 Mutations and polymorphisms in the gene encoding regulatory subunit type 1-α of protein kinase A (PRKAR1A): an update. Hum Mutat 31:369-379
18. Groussin L, Horvath A, Jullian E, Boikos S, Rene-Corail F, Lefebvre H, Cephise-Velayoudom FL, Vantyghem MC, Chanson P, Conte-Devolx B, Lucas M, Gentil A, Malchoff CD, Tissier F, Carney JA, Bertagna X, Stratakis CA, Bertherat J 2006 A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab 91:1943-1949